The Board of Directors of ChengDa Pharmaceuticals Co., Ltd. has authorized a buyback plan on January 9, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.22 CNY | -2.62% |
|
+2.19% | -28.35% |
1st Jan change | Capi. | |
---|---|---|
-28.35% | 38Cr | |
+63.05% | 86TCr | |
+39.42% | 63TCr | |
-4.78% | 36TCr | |
+17.52% | 32TCr | |
+8.43% | 30TCr | |
+14.19% | 24TCr | |
+5.81% | 23TCr | |
+16.77% | 23TCr | |
+14.63% | 18TCr |
- Stock Market
- Equities
- 301201 Stock
- News ChengDa Pharmaceuticals Co., Ltd.
- ChengDa Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.